chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I've experienced PHN from shingles for two years and have been dealing with it. Now,after myvaccine it seems to have gotten a lot worse; After my second dose of Covid vaccine, the pain seemed to get worse.; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (I've experienced PHN from shingles for two years and have been dealing with it. Now,after myvaccine it seems to have gotten a lot worse) and PAIN (After my second dose of Covid vaccine, the pain seemed to get worse.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0468B1A and 007821A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes zoster infection neurological (Nerve pain seems to have increased after 2nd Covid vaccine  Patient experienced Post herpatic neuralgia from shingles for two years and have been dealing with it.) since March 2019, Hypertension, Kidney dysfunction, Coronary artery disorder and Carotid artery stenosis (Bilateral). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LISINOPRIL, METOPROLOL TARTRATE (LOPRESSOR), AMLODIPINE BESILATE (NORVASC), CLOPIDOGREL BISULFATE (PLAVIX), ACETYLSALICYLIC ACID (ECOTRIN), VITAMIN D3, VACCINIUM MACROCARPON (CRANBERRY EXTRACT [VACCINIUM MACROCARPON]) and FISH OIL for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (I've experienced PHN from shingles for two years and have been dealing with it. Now,after myvaccine it seems to have gotten a lot worse) and PAIN (After my second dose of Covid vaccine, the pain seemed to get worse.). At the time of the report, HERPES ZOSTER (I've experienced PHN from shingles for two years and have been dealing with it. Now,after myvaccine it seems to have gotten a lot worse) and PAIN (After my second dose of Covid vaccine, the pain seemed to get worse.) had not resolved.            No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Medical history updated; Concomitant medications added; Events outcome updated and new event added.
Patient had to get  vaccines 3 on left thigh and 3 on right thigh on 1/9/2023. Pt was getting 6 vaccines due to missing the 12 month vaccines.  Had reaction on 1/10/2023 was seen again on 1/10/23. Reaction on both right and left thigh consisted of redness swelling and pain. Treatment on 1/10/2023 to give ibuprofen as needed and apply warm compresses.  Mom called again on 1/11/20233 said reaction getting worse on both thighs. There is more redness and swelling. Provider ordered antibiotic and child will be seen again on 1/13/2023. Unknown which vaccines reacted due to patient having 6.
has not received 2nd shot of moderna vaccine; earache; laryngitis; body feels real bloated; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not received 2nd shot of moderna vaccine), EAR PAIN (earache), LARYNGITIS (laryngitis) and ABDOMINAL DISTENSION (body feels real bloated) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received 2nd shot of moderna vaccine), EAR PAIN (earache), LARYNGITIS (laryngitis) and ABDOMINAL DISTENSION (body feels real bloated). At the time of the report, PRODUCT DOSE OMISSION ISSUE (has not received 2nd shot of moderna vaccine) had resolved and EAR PAIN (earache), LARYNGITIS (laryngitis) and ABDOMINAL DISTENSION (body feels real bloated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was also taking antibiotics prescribed by her doctor and does not know if her side effects are caused by antibiotics or the vaccine. No treatment medication was reported.
On 9/18/01, the vaccinee received his 1st injection of Engerix-B. Thirty minutes later, he had problems focusing, shallow breathing and shakiness. The events lasted 30 minutes. On 10/19/01, the vaccinee received his 2nd injection of Engerix-B (lot ENG5255B6). No adverse events were reported at that time. On 3/21/02, the vaccinee was seen in the office to receive his 3rd injection of Engerix-B. At that time, he reported that 30 minutes after receiving his 2nd injection of Engerix-B, on 10/19/01, he experienced nausea, vomiting, tingling sensation in his right hand, blurred vision, shakiness, weakness and anxiety. The nausea resolved on 10/19/01. As of 3/21/02, the outcome of the vomiting, tingling sensation in his right hand, blurred vision, shakiness, weakness and anxiety were unknown. The 3rd injection of Engerix-B was not administered.
hit me pretty hard; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2, Solution for injection) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (I got both vaccinations, Dose 1), for COVID-19 immunisation. The following information was reported: DISCOMFORT (non-serious), outcome "recovering", described as "hit me pretty hard".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hyponatremia; Fever; This case was received via  (Reference number: 21k-163-3866645-00) on 23-Apr-2021 and was forwarded to Moderna on 05-May-2021.    This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of HYPONATRAEMIA (Hyponatremia) and PYREXIA (Fever) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product VENETOCLAX (VENETOCLAX ABBVIE) tablet for Acute myeloid leukemia.    Patient's medical history was not provided by the reporter.  Concomitant products included ALLOPURINOL, HYDROXYUREA, INSULIN DETEMIR (LEVEMIR), ROSUVASTATIN, GABAPENTIN, LEVOTHYROXINE, VALSARTAN and PARACETAMOL (TYLENOL) for an unknown indication.   On 02-Apr-2021, the patient started VENETOCLAX (VENETOCLAX ABBVIE) (Oral) at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced HYPONATRAEMIA (Hyponatremia) (seriousness criterion hospitalization). On an unknown date, the patient experienced PYREXIA (Fever) (seriousness criterion hospitalization). The patient was hospitalized on sometime in April 2021 due to HYPONATRAEMIA and PYREXIA. At the time of the report, HYPONATRAEMIA (Hyponatremia) and PYREXIA (Fever) had not resolved.            No treatment information was provided.  Very limited information regarding the events has been provided at this time. Additional information regarding name of the vaccine and date of administration, and date of onset for the events are required for further evaluation.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding the events has been provided at this time. Additional information regarding name of the vaccine and date of administration, and date of onset for the events are required for further evaluation.
Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.    On 01-Feb-1900, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I don't know which type of RSV vaccine type I got.  I was ill from the high blood sugar
Patient has an orange size elevation at the injection site. Pt reports pain and itching at the site. The swelling is red and hard.
Hives- Sunday- total body itching left arm red swollen Saturday no fever. No respiratory distress Discrete pustules as well.
Had my shot at 7:05pm on 2/12/21. Woke the next morning with a sore arm at the shot site, slight lump and warm. Around 5:30pm after getting home from work i felt tired, went to lay down , immediatly fell asleep. Woke 2 hours later with shooting pains to both my knees. I have severe arthritis and with every heart beat I felt pain. I also had fever. Around 10pm I took 1 aleve and checked my temp 100.1. The last t time I had checked my temp and that was at midnight it was 99.7. The pain was still there but started to subside. I woke today 2/14/21 and the fever is gone, still feel achy in the knees. I can deal with that.
No additional AE reported; improperly stored vaccines were administered; This spontaneous report was received from an other type of reporter and refers to a 4-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.  On 12-APR-2022, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot #T026960, expiration date: 17-MAR-2023 (strength, site and route of administration were not provided) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #U005994, expiration date: 10-SEP-2022, administered orally (strength was not provided), both for prophylaxis (Product storage error). No adverse events were reported (No adverse event).  On an unknown date, before the vaccination, the vaccines underwent temperature excursion at 67.3 Fahrenheit degrees (F) for 1 hour and 10 minutes. No previous temperature excursions were reported.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL (Lot # K010574 and Lot # K011562, expiration date 08-APR-2017), doses, routes and anatomical locations were not provided. No concomitant medication were reported. No adverse effects reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 21-JAN-2013, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2014, the patient was treated at an emergency care center for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. Also, on an unknown date in 2015, the patient sought subsequent treatment for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
SHe received the vaccine at local pharmacy on Saturday Aug 29, 2021.  The evening of Sunday August 30, 2021 she had insomnia and hallucinations.
A single dose of a Menveo was left in box- unable to determine which of the 4 patients did not receive the entire dose (2 vials- powder and dilutant).  There has not been an adverse reaction to the vaccine- it is not knowing if the patient received the correct dose.
Starting the morning following the vaccine and lasting 4 full days, I was miserable with irregular heartbeat, racing heart, heavy chest, migraine level headache that did not respond to pain relievers, fever of 101+, chills, night sweats, muscle aches, loss of appetite, lethargy, blurry vision the first day. 2 covid tests were negative. It was a horrible, horrible week.
Passed away; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID:.  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant) with onset 2022, outcome "fatal", described as "Passed away". The patient date of death was 2022. The reported cause of death was unknown. It was not reported if an autopsy was performed. Additional information: The reporter said that she keeps receiving a notification card that is from Pfizer Biontech, and they sent this card in her aunt's name (patient). She doesn't understand why they're continuing to send her anything because the patient passed away last year (2022), and she called Pfizer and told them she passed away, and she thought that they had taken care of it. She mentioned that she has nothing to do with Pfizer.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: Passed away
arrhythmia; 1st and 2nd dose of BNT162B2 given on 17Mar2021; This is a spontaneous report from a contactable consumer or other non hcp.   A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration, administered in the left arm on 17Mar2021 at 11:30 AM (pending clarification) as a single dose, and received the second dose (Lot Number: EP7534) via an unspecified route of administration, in the left arm on 17Mar2021 (pending clarification) as single dose for COVID-19 immunisation.  Medical history included long QT syndrome from an unknown date and unknown if ongoing. Relevant concomitant medications included diltiazem.  The patient previously took vancomycin. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced arrhythmia on 18Mar2021 at 16:30. The patient reported, Two days after first dose, I had multiple arrhythmias that were recorded via cardiac defibrillator. The readings were recorded and were printed.  The outcome of the events was unknown.
Redness around site, & itching told to ice and BENADRYL cream called Dr - they will call patient.
Hot sensation in left side of chest; This is a spontaneous report from a non-contactable other healthcare professional. A 35-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot no: EN6205), via an unspecified route of administration on 15Mar2021 (at the age of 35-years-old) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 15Mar2021 after 15 minutes wait period post vaccination, the patient experienced hot sensation in left side of chest. He denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. Therapeutic measures were not taken for event hot sensation in left side of chest. The follow up response to treatment was excellent. Patient was stable to go home and follow up with PCP. The outcome of the event hot sensation in left side of chest was resolved. No follow-up attempts are possible. No further information is expected. Amendment: This follow-up report is being submitted to amend previously reported information: Patient's Age/Units (captured as 35 years per event's onset 15Mar2021), for event: "Treatment Received?" captured as "No" per verbatim "Treatment included: no therapy", "None" removed from concomitant therapy field since not reported if had any con-meds and amended narrative.
BLOOD CLOT; This spontaneous report received from a consumer concerned multiple patients. No past medical histories or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number were not reported and have been requested. No concomitant medications were reported.  On an unspecified dates, multiple patient developed blood clots. As per the reporter," I am worried about the Janssen vaccine because I heard that 2 or 3 patient had blood clots ranging from ages 18 to 49." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcomes for the multiple patients with blood clots was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210829146.; Sender's Comments: V0: 20210849364-COVID-19 VACCINE AD26.COV2.S-blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Initial report was received 13 July 2009 from a health care professional.  A 15-month-old (also reported as a 16 month old) female patient with a history of AMOXIL allergy had received an injection of ACTHIB (route and site not reported), lot number UF595AA (Sanofi Pasteur, SA lot number D0069-1) and an injection of TRIPEDIA, lot number U2471BA on 09 July 2009 and on the evening of vaccination, she developed a generalized rash.  The patient had no concurrent illness and no pre-existing medical conditions.  She had not experienced any adverse events following prior vaccinations.  At the time of the report, the patient's recovery status was unknown.  Follow-up information was received from the health care professional on 17 August 2009.  The patient received ACTHIB in the right thigh, and TRIPEDIA in the left thigh.  The generalized rash persisted three to four days, resolving on 12 July 2009.  The patient was seen by her physician, and treated with BENADRYL (1 tsp PO, Q6h X 2-3 days).  No etiology or diagnosis had been determined.  Documents held by sender: None.
This spontaneous report as received from a nurse practitioner refers to a 14 years old female patient with depression, attention deficit disorder (ADD) and none drug reactions/allergies. The patient was intramuscularly vaccinated with a third dose of 0.5 ml GARDASIL (lot number not provided) on an unknown date. No other co-suspects were reported. Concomitant medications included amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharide, ADDERALL (tablets), TEGRETOL and trazodone hydrochloride. The patient developed a headache and mood swings, after receiving her third dose of GARDASIL approximately in 2012, which "last couple of months". The patient had sought medical attention via contacting the nurse practitioner by the patient's parents. The treatment of TYLENOL was given for headache. There were no laboratory diagnostics studies performed. The outcome of mood swings and headache was reported as not recovered/not resolved. Additional information has been requested.
Narrative: Patient received two COVID 19 vaccine doses Feb/Mar 2021. The patient tested positive and was hospitalized for COVID 19 on 4 August 2021 with COVID pneumonia, fever, and cough. The patient was treated and symptoms improved. The patient was discharged on 6 August 2021. The EUA requires reporting of patients that have received the vaccine who have been hospitalized for COVID 19.
While I did not lose my sense of taste or smell, my tongue felt like I burned it tasting hot liquid.  I noticed a whitish coating  and I started brushing my tongue with my toothbrush.  After a week, the sensation seemed to lessen but hasn't completely gone away.  My sense of taste has also been affected.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/21/2023 PNEUMONIA
Chills, 100.4 Fever, Slight Headache, SEVERE attack of Rheumatoid Arthritis One tablet of Tylenol Chills. fever, cured -- Headache persisted for a couple more days --RA persisted for 6-8 days
I felt fine from the vaccine, what I am concerned about it how it was administered to myself and the health code violations that took place.   I was vaccinated at station. Upon giving me the vaccination (with one glove on) she got my blood all over my paperwork and her counter where she had other unused vaccines for the following recipients.  with her ungloved hand, took a small alcohol wipe, smeared my blood across her counter top and tried to wipe it off my vaccination record and paperwork. This does NOT kill bloodborne pathogens, and as a nurse she is aware of this.  She did not wash her hand that had my blood on it, and proceeded to try to give me my paperwork with blood on it to hand off to the person checking clients out. I asked for a new one that wasn't contaminated. During this entire thing, someone else who was volunteering or working there watched the encounter and didn't interject or say anything.   When I got up she promptly seated another person to get a vaccine without using a hospital grade disinfectant at her station or even washing her hands.   I am a licensed tattooer iwho takes universal precautions extremely seriously, as I would lose my license if I did not or acted the way she did. I approached an EMT to bring it to someone's attention where he told me they were all volunteers and complaining wouldn't accomplish anything, "it's pointless" I was told. I was absolutely disgusted and appalled at what I saw, especially because of my line of work. So much so, that this reckless behavior is making me hesitant to get a second dose.   I figure nothing will happen as a result of me telling you this, I just need to know that I said something about it, because it's truly disgusting and needs to be brought to someone's attention. Hopefully she is instructed to do better and not put other people's health and safety at risk.